Peroxidase in therapy of experimentally induced leprosy.
Maslov
A K
AK
Luzhnova
S A
SA
Kalyanina
O V
OV
D000284:Administration, Oral; D000818:Animals; D003622:Dapsone / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004906:Erythrocyte Count; D006454:Hemoglobins / Q000032:analysis; D006651:Histocytochemistry; D006735:Horseradish Peroxidase / Q000627:therapeutic use*; D007111:Immunity, Cellular; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D009000:Monocytes / Q000276:immunology; D009166:Mycobacterium leprae; D009504:Neutrophils / Q000276:immunology; D009195:Peroxidase / Q000096:biosynthesis / Q000276:immunology; D010586:Phagocytes / Q000276:immunology; D013997:Time Factors
D006454:Hemoglobins; D007917:Leprostatic Agents; D003622:Dapsone; D006735:Horseradish Peroxidase; D009195:Peroxidase